Company / Shares Outstanding
NEKTAR THERAPEUTICS Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
12.4M
FY2025
5-year range
12.4M / 191.4M
FY2021-FY2025
Trend
-93.5%
vs FY2024
Sector context
#206 of 212
Health Care
What the data says
Among 212 Health Care companies, NEKTAR THERAPEUTICS is in the top 3% for shares outstanding. Improved from 188560000.00 to 12385001.00 over the past 2 years.
Based on SEC 10-K filings.
12385001.00 in FY2025 with a 5-year CAGR of -41.2%.
Improved from 188560000.00 to 12385001.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -59.4%
- 5-Year CAGR
- -41.2%
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 212This company 12.4M Sector average 306.0M
▼
-96.0% below sector average
Key checks
Key Insights
- In FY2025, shares outstanding decreased 93.5% year-over-year.
- Ranks #206 out of 212 companies in the Health Care sector.
- Peak shares outstanding was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score -11.97 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 12.4M | -93.5% |
| FY2024 | 191.4M | +1.5% |
| FY2023 | 188.6M | +1.7% |
| FY2022 | 185.5M | +3.0% |
| FY2021 | 180.1M | +2.0% |
| FY2020 | 176.5M | +1.7% |
| FY2019 | 173.5M | +8.8% |
| FY2018 | 159.5M | +4.1% |
| FY2017 | 153.2M | +13.2% |
| FY2016 | 135.3M | +3.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026